Skip to main content
SpringerLink
Log in

Amino acid, ammonia and neurotransmitter concentrations in hepatic encephalopathy: Serial analysis in plasma and cerebrospinal fluid during treatment with an adapted amino acid solution

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

We evaluated changes of advanced liver disease and hepatic encephalopathy on the concentrations of amino acids (AA) and ammonia in plasma and cerebrospinal fluid (CSF) and of the neurotransmitters norepinephrine, dopamine and 5-hydroxytryptamine (5-HT) as well as the 5-hydroxyindole acetic acid (5-HIAA) in CSF before and at the end of a 3-day period of treatment with infusions enriched with branched chain amino acids (BCAA). The subjects studied were 13 patients with alcoholic cirrhosis and hepatic encephalopathy stages 1–3 (n=8) and stage 4 (n=5). The patients in coma stages 1–3 recovered during the treatment (survivors), those in coma stage 4 died before the study period was finished (non-survivors). The data emerging from this study show:

  1. 1.

    Alterations of AA concentrations are much more pronounced in the CSF than in the plasma. In the case of tryptophan the alterations in plasma and CSF were inverse.

  2. 2.

    Before the treatment the CSF-plasma ratios of the concentrations of BCAA and aromatic amino acids (AAA) are increased reflecting an activated transport of both the BCAA and AAA through the blood-brain barrier.

  3. 3.

    High dose BCAA nearly normalized CSF concentrations and CSF-plasma ratios of AAA assuming that the treatment brought about an effective competition of cerebral uptake between BCAA and AAA.

  4. 4.

    The CSF concentrations of ammonia and glutamine decreased significantly during treatment while the plasma concentrations changed only moderately.

  5. 5.

    As to the neurotransmitters, only the concentrations of 5-HT and its metabolite 5-HIAA correlated with the clinical picture and with the concentration of their precursor AA.

  6. 6.

    The normalization or improvement of the CSF concentrations of the AAA, ammonia and glutamine as well as the neurotransmitter 5-HT were accompanied by an improvement of hepatic encephalopathy stages 1–3.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AA:

amino acid

AAA:

aromatic amino acids

ALA:

alanine

ASN:

asparagine

BCAA:

branched chain amino acids

CSF:

cerebrospinal fluid

GABA:

gamma-aminobutyric acid

GLN:

glutamine

GLY:

glycine

HE:

hepatic encephalopathy

5-HIAA:

5-hydroxyindoleacetic acid

5-HT:

5-hydroxytryptamine

ILE:

isoleucine

LEU:

leucine

MET:

methionine

PHE:

phenylalanine

SER:

serine

THR:

threonine

TRP:

tryptophan

TYR:

tyrosine

VAL:

valine

References

  1. Ashcroft GW, Sharman FD (1962) Drug induced changes in the concentration of 5-OR indolyl compounds in the cerebrospinal fluid and caudate nucleus. Br J Pharmacol 19:153–160

    CAS  Google Scholar 

  2. Bloxam OL, Warren WH (1974) Error in the determination of tryptophan by the method of Denkla and Dewey. A revised procedure. Anal Biochem 60:621–624

    Article  CAS  PubMed  Google Scholar 

  3. Cerra FB, Cheung NK, Fischer JE (1982) A multicenter trial of branched-chain enriched amino acid infusion (FO80) in hepatic encephalopathy (HE). Hepatology 2:699

    Google Scholar 

  4. Conn HO (1977) Trailmaking and number connection tests in the assessment of mental state in portal-systemic encephalopathy. Am J Dig Dis 22:541–550

    Article  CAS  PubMed  Google Scholar 

  5. Cummings MC, Soeters PB, James JH, Fischer JE (1976) Regional brain indoleamine metabolism following chronic portacaval anastomosis in the rat. J Neurochem 27:501–509

    Article  CAS  PubMed  Google Scholar 

  6. Da Fonseca-Wollheim (1973) Bedeutung von Wasserstoffionenkonzentration und ADP-Zusatz bei der Ammoniakbestimmung mit Glutamatdehydrogenase. Z Klin Chem Klin Biochem 11:421–425

    Google Scholar 

  7. Da Prada M, Zürcher G (1976) Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the fentomole range. Life Sci 19:1161–1174

    Article  PubMed  Google Scholar 

  8. Dodsworth JM, James JH, Cummings MC, Fischer JE (1974) Depletion of brain norepinephrine in acute hepatic coma. Surgery 75:811–820

    CAS  PubMed  Google Scholar 

  9. Egberts EM, Hamster W, Jurgens P (1981) Effects of branched-chain amino acids on latent portal-systemic encephalopathy in Metabolism and Clinical Implications of Branched-Chain Amino and Ketoacids. Walser M, Williamson JR (eds). Elsevier N Holland, New York, pp 453–465

    Google Scholar 

  10. Eriksson LS, Persson A, Wahren J (1982) Branched chain amino acids in the treatment of chronic hepatic encephalopathy. Gut 23:801–806

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Fernstrom JD, Wurtman RJ (1972) Brain serotonin content: physiological regulation by plasma amino acids. Science 178:414–416

    Article  CAS  PubMed  Google Scholar 

  12. Fischer JE, Yoshimura M, Aguirre A (1974) Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions. Am J Surg 127:40–47

    Article  CAS  PubMed  Google Scholar 

  13. Fischer JE, Funovics JM, Aguirre A, James JH, Keane JM, Westdrop RIC, Yoshimura M, Westman T (1975) The role of plasma amino acids in hepatic encephalopathy. Surgery 78:276–290

    CAS  PubMed  Google Scholar 

  14. Fischer JE, Rosen H, Ebeid AM, James JH, Keane JM Soeters PB (1976) The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 80:77–91

    CAS  PubMed  Google Scholar 

  15. Fischer JE, Freund H, Rosen H, Yoshimura M, Bradford R, Sofio C (1978) Effects of FO80 in clinical hepatic encephalopathy: result of a phase I study. Gastroenterology 75:963

    Google Scholar 

  16. Freund H, Yoshimura M, Fischer JE (1979) Chronic hepatic encephalopathy. Long-term therapy with a branched-chain-amino-acid-enriched elemental diet. JAMA 242:347–349

    Article  CAS  PubMed  Google Scholar 

  17. Garelis E, Young SN, Lal S, Sourkes TL (1974) Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies. Brain Res 93:357–368

    Google Scholar 

  18. Gerok W (1963) Quantitative Bestimmung der Aminosäuren im Serum bei Erkrankungen der Leber. Dtsch Med Wochenschr 88:1189–1197

    Article  Google Scholar 

  19. Gimmon Z, James JH, Fischer JE (1980) Branched chain amino acids (BC) reduce the accumulation in the brain of glutamine and aromatic amino acids (AAA) induced by ammonia infusion. Gastroenterology 79:1020

    Google Scholar 

  20. Higashi T, Watanabe A, Hayashi S, Obata T, Takei N, Nagashims H (1981) Effect of branched chain amino acid infusion on alterations in CSF neutral amino acids and their transport across the blood brain barrier in hepatic encephalopathy in Metabolism and Clinical Implications of Branched-Chain Amino and Ketoacids. Walser M, Williamson R (eds). Elsevier N Holland, New York, pp 465–470

    Google Scholar 

  21. Holm E, Striebel JP, Moller P (1981) Amino acid solutions for parenteral nutrition and for adjuvant treatment of encephalopathy in liver cirrhosis, studies concerning 120 patients in Metabolism and Clinical Implications of Branched-Chain Amino and Ketoacids. Walser M, Williamson R (eds). Elsevier N Holland, New York, pp 513–518

    Google Scholar 

  22. Horst D, Grace N, Conn HO (1981) A double-blind randomized comparison of dietary protein and an oral branched chain amino acid (BCAA) supplement in cirrhotic patients with chronic portal-systemic encephalopathy. Hepatology 1:518

    Google Scholar 

  23. James JH, Escourrou J, Fischer JE (1978) Blood-brain neutral amino acid transport activity is increased after portacaval anastomosis. Science 200:1395–1397

    Article  CAS  PubMed  Google Scholar 

  24. Jellinger K, Riederer P (1977) Brain monoamines in metabolic (endotoxic) coma. A preliminary biochemical study in human post mortem material. J Neural Transm 41:275–286

    Article  CAS  PubMed  Google Scholar 

  25. Jellinger K, Riederer P, Kothbauer P (1978) Brain monoamines in human cerebral infarcts. A preliminary study. Acta Neuropathol (Berl) 41:173–176

    Article  CAS  PubMed  Google Scholar 

  26. Jellinger K, Riederer P, Rausch WD (1978) Brain monoamines in hepatic encephalopathy and other types of metabolic comata. J Neural Transm 14 [Suppl]:103–120

    CAS  Google Scholar 

  27. Jeppson B, Gimmon Z, James JH, Nobin A, Fischer JE (1980) Infusion of NH +4 -salts changes brain neurotransmitters. Gastroenterology 79:1028

    Google Scholar 

  28. Knell AJ, Davidson AR, Williams R, Kantamaneni BD, Curzon G (1974) Dopamine and serotonin metabolism in hepatic encephalopathy. Br Med J 1:549–551

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Mattson WJ, Iob V, Sloan M, Coon WW, Turcotte JG, Child CG (1970) Alterations of individual free amino acids in brain during acute hepatic coma. Surg Gynecol Obstet 130:263–266

    CAS  PubMed  Google Scholar 

  30. Moir ATB, Ashcroft GW, Crawford TBB, Eccleston D, Guldberg HC (1970) Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain. Brain 93:357–368

    Article  CAS  PubMed  Google Scholar 

  31. Munro HN, Fernstrom JD, Wurtman RJ (1975) Insulin, plasma amino acid imbalance, and hepatic coma. Lancet 29:722–724

    Article  Google Scholar 

  32. Oldendorf WH (1973) Brain uptake of radiolabelled amino acids, amines and hexoses after arterial injection. Am J Physiol 221:1629–1639

    Google Scholar 

  33. Ono J, Hutson DG, Dombro RS (1978) Tryptophan and hepatic coma. Gastroenterology 74:196–200

    CAS  PubMed  Google Scholar 

  34. Pardridge WM, Oldendorf WH (1975) Kinetic analysis of blood-brain barrier transport of amino acids. Biochim Biophys Acta 401:128–136

    Article  CAS  PubMed  Google Scholar 

  35. Parson-Smith BL, Summerskill WHJ, Dawson AM (1957) The electroencephalograph in liver disease. Lancet 2:867–871

    Article  Google Scholar 

  36. Record CO, Buxton B, Chase RA, Curzon G, Murray-Lyon IM, Williams R (1976) Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest 5:387–394

    Article  Google Scholar 

  37. Riederer P, Jellinger K, Kleinberger G, Weiser M (1980) Oral and parenteral nutrition with L-valine: mode of action. Nutr Metab 24:209–217

    Article  CAS  PubMed  Google Scholar 

  38. Rossi-Fanelli F, Riggio O, Cangiano C (1982) Branched-chain amino acids vs. lactulose in the treatment of hepatic coma: a controlled study. Dig Dis Sci 27:929

    Article  CAS  PubMed  Google Scholar 

  39. Smith AR, Rossi-Fanelli F, Ziparo V, James JH, Perelle BA, Fischer JE (1978) Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann Surg 187:343–350

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Schafer DF, Thakur AK, Jones EA (1980) Increased gamma-aminobutyric acid receptors associated with acute hepatic encephalopathy in rabbits. Clin Res 28:485

    Google Scholar 

  41. Schafer DF, Waggoner JG, Jones EA (1980) Sera from rabbits in acute hepatic coma inhibit the binding of (3H) gamma-aminobutyric acid to neural membranes. Gastroenterology 78:1320

    Google Scholar 

  42. Schafer DF, Thakur AK, Jones EA (1980) Acute hepatic coma and inhibitory neurotransmission: increase of gamma-amino-butyric acid levels in plasma and receptors in brain. Gastroenterology 79:1123

    Google Scholar 

  43. Tapia R (1980) Glutamine metabolism in brain. In: Mora J, Palacios R (eds) Glutamine: metabolism, enzymology and regulation. Academic Press, New York, 285:297

    Google Scholar 

  44. Wahren JJ, Denis J, Desurmont P (1981) Is iv administration of branched chain amino acids effective in the treatment of hepatic encephalopathy of multicenter study? Eur Soc Parent Enter Nutr FC 47:61

    Google Scholar 

  45. Warren KS, Schenker S (1964) Effect of an inhibitor of glutamine synthesis (methionine sulfoximine) on ammonia toxicity and metabolism. J Lab Clin Med 64:442–449

    CAS  PubMed  Google Scholar 

  46. Wurtman RJ, Hefti F, Melamed E (1981) Precursor control of neurotransmitter synthesis. Pharmacol Rev 32:315–335

    Google Scholar 

  47. Zieve L (1981) The metabolism of hepatic coma. Hepatology 1:360–365

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Universitätsklinik Freiburg im Breisgau, Germany

    M. Rössle, M. Luft, R. Herz, B. Klein, M. Lehmann & W. Gerok

Authors
  1. M. Rössle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Luft
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Herz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Lehmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. Gerok
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rössle, M., Luft, M., Herz, R. et al. Amino acid, ammonia and neurotransmitter concentrations in hepatic encephalopathy: Serial analysis in plasma and cerebrospinal fluid during treatment with an adapted amino acid solution. Klin Wochenschr 62, 867–875 (1984). https://doi.org/10.1007/BF01712006

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01712006

Key words

Search

Navigation